Health Enterprise Partners

Health Enterprise PartnersHealth Enterprise Partners
Health Enterprise Partners

Health Enterprise Partners

Growth equity firm investing in lower middle-market healthcare IT and services companies.

2007PE1 portfolio$600.0M AUMNew York, United States

About

Health Enterprise Partners (HEP) is a private equity firm focused on growth equity and small buyouts within the healthcare sector. They partner with innovative healthcare services and information technology companies, leveraging their extensive network of hospital systems and health plans to improve patient experience, expand access, and reduce healthcare costs.
Frequently asked

What type of investor is Health Enterprise Partners?

Health Enterprise Partners (HEP) is a private equity firm focused on growth equity and small buyouts within the healthcare sector. They partner with innovative healthcare services and information technology companies, leveraging their extensive network of hospital systems and health plans to improve patient experience, expand access, and reduce healthcare costs.

What kind of firm is Health Enterprise Partners?

Health Enterprise Partners is a PE.

What is Health Enterprise Partners's assets under management?

Health Enterprise Partners manages approximately $600M in assets.

Where is Health Enterprise Partners based?

Health Enterprise Partners is based in New York, United States.

What sectors does Health Enterprise Partners focus on?

Health Enterprise Partners focuses on Healthcare Technology, Technology-Enabled Services, Healthcare Services, Administrative Automation.

AUM
$600M
PORTFOLIO
1
Scores
Measured, not editorial
Domain Rating
26/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Check any domain free

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.